Susquehanna International Group, LLP Insmed Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Insmed Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 261,546 shares of INSM stock, worth $19.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

261,546

Previous 151,024 73.18%

Holding current value

$19.3 Million

Previous $10.1 Million 88.69%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $6.85 Million - $8.73 Million	110,522 Added 73.18%	261,546 $19.1 Million
Q2 2024 Aug 15, 2024	BUY	$22.0 - $69.71 $121,572 - $385,217	5,526 Added 3.8%	151,024 $10.1 Million
Q1 2024 May 07, 2024	BUY	$25.72 - $29.94 $747,217 - $869,816	29,052 Added 24.95%	145,498 $3.95 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $3.22 Million - $4.36 Million	-137,396 Reduced 54.13%	116,446 $3.61 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $48,915 - $66,328	-2,463 Reduced 0.96%	253,842 $6.41 Million
Q2 2023 Aug 11, 2023	SELL	$16.44 - $21.1 $971,620 - $1.25 Million	-59,101 Reduced 18.74%	256,305 $5.41 Million
Q1 2023 May 16, 2023	BUY	$16.26 - $21.73 $4.52 Million - $6.05 Million	278,240 Added 748.64%	315,406 $5.38 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $2.38 Million - $3.25 Million	-140,319 Reduced 79.06%	37,166 $742,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $2.53 Million - $3.42 Million	121,356 Added 216.21%	177,485 $3.82 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $391,824 - $590,147	-22,954 Reduced 29.03%	56,129 $1.11 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $126,032 - $173,618	-6,172 Reduced 7.24%	79,083 $1.86 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $180,789 - $233,581	6,983 Added 8.92%	85,255 $2.32 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $727,636 - $954,739	32,397 Added 70.62%	78,272 $2.16 Million
Q2 2021 Aug 11, 2021	BUY	$24.17 - $36.01 $475,013 - $707,704	19,653 Added 74.95%	45,875 $1.31 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $199,070 - $273,198	-6,167 Reduced 19.04%	26,222 $893,000
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $13,303 - $17,148	-423 Reduced 1.29%	32,389 $1.08 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $40,794 - $54,130	1,569 Added 5.02%	32,812 $1.05 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $611,005 - $1.27 Million	-43,303 Reduced 58.09%	31,243 $861,000
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $687,946 - $1.72 Million	-50,473 Reduced 40.37%	74,546 $1.2 Million
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $807,998 - $1.25 Million	-50,124 Reduced 28.62%	125,019 $2.99 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $838,148 - $1.39 Million	54,109 Added 44.71%	175,143 $3.09 Million
Q2 2019 Aug 16, 2019	BUY	$23.0 - $32.19 $294,584 - $412,289	12,808 Added 11.83%	121,034 $3.1 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $2.49 Million - $3.48 Million	108,226 New	108,226 $2.77 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Insmed Inc Transaction History